MeiraGTx Holdings plc
About MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $81.4M
- Net income
- -$114.2M
- Total assets
- $244.4M
- Market cap
- $833.5M
- Operating margin
- -130.2%
- Net margin
- -140.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $81.4M
- Operating expenses
- $187.4M
- Operating income
- -$106.0M
- Income tax
- -$21.3M
- Net income
- -$114.2M
- EPS (basic)
- $-1.42
- EPS (diluted)
- $-1.42
Balance sheet
- Total assets
- $244.4M
- Current assets
- $91.8M
- Total liabilities
- $250.2M
- Current liabilities
- $122.6M
- Shareholders’ equity
- -$5.8M
Cash flow
- Operating cash flow
- -$46.4M
- Investing cash flow
- -$4.1M
- Financing cash flow
- $12.3M
- Net cash flow
- -$37.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $833.5M
- EPS (diluted)
- $-1.42
- Shares outstanding
- 91.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 8, 2018
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $114.2M in FY2025.
- Revenue grew 116% from FY2021 to FY2025.
- Trading 19% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review MeiraGTx Holdings plc.
Write a review
News about MeiraGTx Holdings plc
News & sentiment via Polygon.io
